ID

36435

Beschreibung

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets; ODM derived from: https://clinicaltrials.gov/show/NCT01510522 Brief Summary: This is an open-label, multicenter, two-arm, parallel, randomized phase 4 study to compare the compliance in diabetes type 2 patients treated with Glucophage sachets versus patients treated with Glucophage tablets.

Link

https://clinicaltrials.gov/show/NCT01510522

Stichworte

Versionen (2)
  1. 16.01.19 16.01.19 -
  2. 14.05.19 14.05.19 -
Rechteinhaber

Merck KGaA, Darmstadt, Germany

Hochgeladen am

14. Mai 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Adherence to Glucophage Sachets vs Tablets in Type 2 Diabetes NCT01510522

Englisch

Eligibility Criteria

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
Is type 2 diabetes diagnosed?
Beschreibung

Diabetes mellitus type 2 should be diagnosed: baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl) as criteria

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
Is the patient being treated with metformin tablets?
Beschreibung

Metformin treatment

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0039225
Does the patient have at least 2 comorbidities?
Beschreibung

Patients shoudl have at least 2 treated co-morbidities

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
Does the patient have an established dose of metformin > 1.700 mg/day?
Beschreibung

Patients should have an established dose of metformin > 1.700 mg/day

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C2348070
UMLS CUI [1,3]
C0443211
Is the patient over 18 years old?
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
Is informed consent given?
Beschreibung

Informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
Is the patient able to take medication orally?
Beschreibung

Patients not able to take medication orally should be excluded

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0175795
Are there exclusions given according to summary of product characteristics (smpc)?
Beschreibung

Are there exclusions given according to summary of product characteristics (smpc)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0332290
UMLS CUI [1,3]
C1709515
Does the patient participate in another clinical trial 30 days prior to randomization?
Beschreibung

Different clinical trial

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0332185
Are the any other illness or medical or psychiatric conditions, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results?
Beschreibung

Other confounding illnesses

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0205318
UMLS CUI [1,4]
C0521102
UMLS CUI [1,5]
C2348568
UMLS CUI [2,1]
C0221423
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0205318
UMLS CUI [2,4]
C0521102
UMLS CUI [2,5]
C0683954
UMLS CUI [3,1]
C0205476
UMLS CUI [3,2]
C0348080
UMLS CUI [3,3]
C0205082
UMLS CUI [3,4]
C0205318
UMLS CUI [3,5]
C0521102
UMLS CUI [3,6]
C2348568
UMLS CUI [4,1]
C0205476
UMLS CUI [4,2]
C0348080
UMLS CUI [4,3]
C0205082
UMLS CUI [4,4]
C0205318
UMLS CUI [4,5]
C0521102
UMLS CUI [4,6]
C0683954
UMLS CUI [5,1]
C0004936
UMLS CUI [5,2]
C0205082
UMLS CUI [5,3]
C0205318
UMLS CUI [5,4]
C0521102
UMLS CUI [5,5]
C2348568
UMLS CUI [6,1]
C0004936
UMLS CUI [6,2]
C0205082
UMLS CUI [6,3]
C0205318
UMLS CUI [6,4]
C0521102
UMLS CUI [6,5]
C0683954
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Criteria

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Diagnosed type 2 diabetes
Item
Is type 2 diabetes diagnosed?
boolean
C0011860 (UMLS CUI [1])
Metformin treatment
Item
Is the patient being treated with metformin tablets?
boolean
C0025598 (UMLS CUI [1,1])
C0039225 (UMLS CUI [1,2])
Comorbidities
Item
Does the patient have at least 2 comorbidities?
boolean
C0009488 (UMLS CUI [1])
Daily Metformin dose
Item
Does the patient have an established dose of metformin > 1.700 mg/day?
boolean
C0025598 (UMLS CUI [1,1])
C2348070 (UMLS CUI [1,2])
C0443211 (UMLS CUI [1,3])
Age
Item
Is the patient over 18 years old?
boolean
C0001779 (UMLS CUI [1])
Informed consent
Item
Is informed consent given?
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Ability to take medication p.o.
Item
Is the patient able to take medication orally?
boolean
C2712086 (UMLS CUI [1,1])
C0175795 (UMLS CUI [1,2])
Exclusion by SMPC
Item
Are there exclusions given according to summary of product characteristics (smpc)?
boolean
C0680251 (UMLS CUI [1,1])
C0332290 (UMLS CUI [1,2])
C1709515 (UMLS CUI [1,3])
Different clinical trial
Item
Does the patient participate in another clinical trial 30 days prior to randomization?
boolean
C2348568 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Other confounding illnesses
Item
Are the any other illness or medical or psychiatric conditions, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results?
boolean
C0221423 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,4])
C2348568 (UMLS CUI [1,5])
C0221423 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0205318 (UMLS CUI [2,3])
C0521102 (UMLS CUI [2,4])
C0683954 (UMLS CUI [2,5])
C0205476 (UMLS CUI [3,1])
C0348080 (UMLS CUI [3,2])
C0205082 (UMLS CUI [3,3])
C0205318 (UMLS CUI [3,4])
C0521102 (UMLS CUI [3,5])
C2348568 (UMLS CUI [3,6])
C0205476 (UMLS CUI [4,1])
C0348080 (UMLS CUI [4,2])
C0205082 (UMLS CUI [4,3])
C0205318 (UMLS CUI [4,4])
C0521102 (UMLS CUI [4,5])
C0683954 (UMLS CUI [4,6])
C0004936 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
C0205318 (UMLS CUI [5,3])
C0521102 (UMLS CUI [5,4])
C2348568 (UMLS CUI [5,5])
C0004936 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
C0205318 (UMLS CUI [6,3])
C0521102 (UMLS CUI [6,4])
C0683954 (UMLS CUI [6,5])
Zum Seitenanfang zurückkehren 

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video